Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Decision Aids Help Your Shared Decision Making

Decision Aids Help Your Shared Decision Making EDITORIAL ONLINE FIRST ATIENTS WITH PLAQUE PSORIASIS NOW HAVE step further and demonstrate that PtDAs are eminently fea- an array of treatments to choose from. These sible for multiple options and reflect what patients and cli- have shown to be efficacious in random- nicians discuss in real life, which is also the focus of the ized controlled trials, in which, generally, Obama administration’s legislation on Comparative Effec- P the benefits outweigh the harms in more pa- tiveness and the Patient-Centered Outcomes Research In- 7,8 tients in the treatment arm than those receiving a pla- stitute (PCORI) initiative. cebo. However, the decision is not clear for individual Decision aids have been demonstrated to be one of the patients because it is “preference sensitive,” where the most effective tools to promote shared decision mak- right balance of benefits and harms depends, in great mea- ing. When used jointly with “traditional” counseling, de- sure, on the weight or value that a person gives to the cision aids improve decision quality (defined as the agree- benefits and harms. In this context, shared decision mak- ment between patient choice and patient values) and ing between the patient and the practitioner is essential reduce the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Decision Aids Help Your Shared Decision Making

Loading next page...
 
/lp/american-medical-association/decision-aids-help-your-shared-decision-making-yrMnRglDr3
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archdermatol.2012.1331
pmid
22710452
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL ONLINE FIRST ATIENTS WITH PLAQUE PSORIASIS NOW HAVE step further and demonstrate that PtDAs are eminently fea- an array of treatments to choose from. These sible for multiple options and reflect what patients and cli- have shown to be efficacious in random- nicians discuss in real life, which is also the focus of the ized controlled trials, in which, generally, Obama administration’s legislation on Comparative Effec- P the benefits outweigh the harms in more pa- tiveness and the Patient-Centered Outcomes Research In- 7,8 tients in the treatment arm than those receiving a pla- stitute (PCORI) initiative. cebo. However, the decision is not clear for individual Decision aids have been demonstrated to be one of the patients because it is “preference sensitive,” where the most effective tools to promote shared decision mak- right balance of benefits and harms depends, in great mea- ing. When used jointly with “traditional” counseling, de- sure, on the weight or value that a person gives to the cision aids improve decision quality (defined as the agree- benefits and harms. In this context, shared decision mak- ment between patient choice and patient values) and ing between the patient and the practitioner is essential reduce the

Journal

JAMA DermatologyAmerican Medical Association

Published: Jun 1, 2012

References